Myeloid cells and lymphangiogenesis

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 6, 2012, Pages

  Zumsteg, Adrian ^a   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COLONY STIMULATING FACTOR; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRACTALKINE; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; LYMPHATIC VESSEL ENDOTHELIAL RECEPTOR 1; LYMPHOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE C GAMMA2; PLACENTAL GROWTH FACTOR; PODOPLANIN; PROTEIN KINASE SYK; RANTES; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXC2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AMPHIBIA; ANGIOGENESIS; ARTICLE; BIRD; BONE MARROW CELL; CELL CONTACT; EMBRYO DEVELOPMENT; GENE EXPRESSION; HEMATOPOIETIC CELL; HEMATOPOIETIC SYSTEM; HUMAN; INFLAMMATION; LEUKOCYTE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHOBLAST; MAMMAL; NEOPLASM; NONHUMAN; PLASTICITY; SPECIES; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CELL DEDIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; LYMPH VESSEL ENDOTHELIUM; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW;

AMPHIBIA; AVES; MAMMALIA;

ANIMALS; CELL DEDIFFERENTIATION; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; HEMATOPOIETIC SYSTEM; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MYELOID CELLS;

EID: 84886687200     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006494     Document Type: Article

References (76)

1. Abtahian F, Guerriero A, Sebzda E, Lu MM, Zhou R, Mocsai A, Myers EE, HuangB, Jackson DG, Ferrari VA, et al. 2003. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299: 247-251.
2. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. 2008. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9.
3. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, Skobe M, JessbergerR, Merad M, Randolph GJ. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24: 203-215.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, WitzenbichlerB, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
5. + macrophages in the human onchocerca nodule. PLoS One 4: e8234.
6. Aurora AB, Baluk P, Zhang D, Sidhu SS, Dolganov GM, Basbaum C, McDonaldDM, Killeen N. 2005. Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol 175: 6319-6326.
7. Bais C, Wu X, Yao J, Yang S, Crawford Y, McCutcheon K, Tan C, Kolumam G, Vernes JM, Eastham-Anderson J, et al. 2010. PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell 141: 166-177.
8. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115: 247-257.
9. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, Yan L, Shealy DJ, McDonald DM. 2009. TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119: 2954-2964.
10. Bergers G, Hanahan D. 2008. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8: 592-603.
11. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen CY, Xu B, Lu MM, Zhou D, et al. 2010. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116: 661-670.
12. Bingle L, Brown NJ, Lewis CE. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196: 254-265.
13. + leukocytes. Dev Cell 18: 437-449.
14. Buttler K, Kreysing A, von Kaisenberg CS, Schweigerer L, Gale N, Papoutsi M, Wilting J. 2006. Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Dev Dyn 235: 1554-1562.
15. Buttler K, Ezaki T, Wilting J. 2008. Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. BMC Dev Biol 8: 43.
16. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. 2009. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 457: 887-891.
17. Cumano A, Godin I. 2007. Ontogeny of the hematopoietic system. Annu Rev Immunol 25: 745-785.
18. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Weigand SJ, Streilein JW. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050.
19. Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, Jahnke K, Hauschild A, Hirakawa S, Mihm MC, et al. 2005. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18: 1232-1242.
20. El-Chemaly S, Malide D, Zudaire E, Ikeda Y, Weinberg BA, Pacheco-RodriguezG, Rosas IO, Aparicio M, Ren P, MacDonald SD, et al. 2009. Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci 106: 3958-3963.
21. Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, et al. 2007. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131: 463-475.
22. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S. 2010. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1. Blood 115: 418-429.
23. Franchi A, Massi D, Santucci M, Masini E, Degl'Innocenti DR, Magnelli L, FantiE, Naldini A, Ardinghi C, Carraro F, et al. 2006. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 208: 439-445.
24. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. 2005. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167: 835-848.
25. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M. 2007. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110: 3158-3167.
26. Hamrah P, Chen L, Zhang Q, Dana MR. 2003. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol 163: 57-68.
27. Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. 2004. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res 79: 553-561.
28. He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. 2004. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64: 3737-3740.
29. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. 2005. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099.
30. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. 2006. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109: 1010-1017.
31. Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, et al. 2007. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67: 10181-10189.
32. + macrophages in advanced ovarian cancer. Cancer Res 68: 1100-1109.
33. Jiang S, Bailey AS, Goldman DC, Swain JR, Wong MH, Streeter PR, Fleming WH. 2008. Hematopoietic stem cells contribute to lymphatic endothelium. PLoS ONE3: e3812.
34. Kang S, Lee SP, Kim KE, Kim HZ, Memet S, Koh GY. 2009. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 113: 2605-2613.
35. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
36. + macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113: 5650-5659.
37. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, KroberSM, Greinix H, Rosenmaier A, Karlhofer F, et al. 2006. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12: 230-234.
38. Kim SF, Huri DA, Snyder SH. 2005. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970.
39. + macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 175: 1733-1745.
40. Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K. 2001. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66: 159-164.
41. Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T. 2009. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206: 1089-1102.
42. Li Z, Chen MJ, Stacy T, Speck NA. 2006. Runx1 function in hematopoiesis is required in cells that express Tek. Blood 107: 106-110.
43. Lin EY, Nguyen AV, Russell RG, Pollard JW. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727-740.
44. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzeski DA, Qian H, Xue XN, PollardJW. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246.
45. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, ParkJK, Beck FX, Muller DN, Deer W, et al. 2009. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15: 545-552.
46. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, et al. 2005. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115: 2363-2372.
47. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. 2007. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170: 1178-1191.
48. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
49. + progenitor: Contribution to muscle lineage. Genesis 35: 153-159.
50. Murakami M, Zheng Y, Hirashima M, Suda T, Moriat Y, Ooehara J, Ema H, FongGH, Shibuya M. 2008. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol 28: 658-664.
51. Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD, Graham GJ. 2007. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 117: 1884-1892.
52. Oliver G. 2004. Lymphatic vasculature development. Nat Rev Immunol 4: 35-45.
53. Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, Randolph GJ, Skobe M. 2009. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol 183: 1767-1779.
54. Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y. 2005. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106: 4184-4190.
55. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273: 8413-8418.
56. +CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314-322.
57. Saaristo A, Tammela T, Farkkilä A, Kärkkäinen M, Suominen E, Yla-Hertuala S, Alitalo K. 2006. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 169: 1080-1087.
58. + lymphatic/vascular endothelial precursor cells. Blood 101: 168-172.
59. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947-956.
60. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
61. Siriwardena BS, Kudo Y, Ogawa I, Udagama MN, Tilakaratne WM, Takata T. 2008. VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clin Pathol 61: 103-108.
62. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, DetmarM. 2001. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159: 893-903.
63. Slack JM. 2007. Metaplasia and transdifferentiation: From pure biology to the clinic. Nat Rev Mol Cell Biol 8: 369-378.
64. Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S, Tsai MJ, Samokhvalov IM, Oliver G. 2007. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 21: 2422-2432.
65. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. 2002. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583.
66. Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wie LH, Yang PC, KuoML. 2004. Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: A novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64: 554-564.
67. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
68. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
69. Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fassler R, et al. 2010. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115: 3997-4005.
70. Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, Schmidt T, Loges S, Albrecht I, Jonckx B, Vinckier S, et al. 2010. Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178-190.
71. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
72. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, GustafssonE, Chandraker A, Yuan X, Pu WT, Roberts AB, et al. 2007. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961.
73. Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY. 2008. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 8: 4.
74. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. 2008. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455: 627-632.
75. Zumsteg A, Christofori G. 2009. Corrupt policemen: Inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 21: 60-70.
76. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. 2009. Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4: e7067.